25 XP   0   0   10

Celyad SA
Buy, Hold or Sell?

Let's analyse Celyad together

PenkeI guess you are interested in Celyad SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Celyad SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Celyad SA

I send you an email if I find something interesting about Celyad SA.

Quick analysis of Celyad (30 sec.)










What can you expect buying and holding a share of Celyad? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-0.25
Expected worth in 1 year
€-0.19
How sure are you?
20.5%

+ What do you gain per year?

Total Gains per Share
€0.06
Return On Investment
20.8%

For what price can you sell your share?

Current Price per Share
€0.31
Expected price per share
€0.2975 - €0.47
How sure are you?
50%

1. Valuation of Celyad (5 min.)




Live pricePrice per Share (EOD)

€0.31

Intrinsic Value Per Share

€-9.07 - €-8.56

Total Value Per Share

€-9.32 - €-8.80

2. Growth of Celyad (5 min.)




Is Celyad growing?

Current yearPrevious yearGrowGrow %
How rich?-$11.1m$23m-$30.7m-396.5%

How much money is Celyad making?

Current yearPrevious yearGrowGrow %
Making money-$3.7m-$14.5m$10.8m294.2%
Net Profit Margin-5,539.1%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Celyad (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#945 / 1007

Most Revenue
#625 / 1007

Most Profit
#553 / 1007

Most Efficient
#930 / 1007

What can you expect buying and holding a share of Celyad? (5 min.)

Welcome investor! Celyad's management wants to use your money to grow the business. In return you get a share of Celyad.

What can you expect buying and holding a share of Celyad?

First you should know what it really means to hold a share of Celyad. And how you can make/lose money.

Speculation

The Price per Share of Celyad is €0.308. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Celyad.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Celyad, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-0.25. Based on the TTM, the Book Value Change Per Share is €0.02 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.34 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Celyad.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.12-39.7%-0.07-23.8%-0.27-86.3%-0.18-59.9%-0.21-67.8%
Usd Book Value Change Per Share-0.29-95.7%0.025.6%-0.36-118.0%-0.09-29.3%-0.02-5.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.29-95.7%0.025.6%-0.36-118.0%-0.09-29.3%-0.02-5.9%
Usd Price Per Share0.42-0.63-1.58-5.91-21.20-
Price to Earnings Ratio-0.86--2.82--1.81--19.36--36.24-
Price-to-Total Gains Ratio-1.42-0.10--8.41--6.46--1,018,242.56-
Price to Book Ratio-1.56-5.60-1.27-7.18-15.72-
Price-to-Total Gains Ratio-1.42-0.10--8.41--6.46--1,018,242.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.331562
Number of shares3016
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.02-0.09
Usd Total Gains Per Share0.02-0.09
Gains per Quarter (3016 shares)51.91-271.88
Gains per Year (3016 shares)207.63-1,087.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102081980-1088-1098
204154060-2175-2186
306236140-3263-3274
408318220-4350-4362
50103810300-5438-5450
60124612380-6525-6538
70145314460-7613-7626
80166116540-8700-8714
90186918620-9788-9802
100207620700-10875-10890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.03.00.00.0%0.011.00.00.0%0.019.00.00.0%0.039.00.00.0%0.049.00.00.0%
Book Value Change Per Share1.01.01.033.3%2.07.02.018.2%4.09.06.021.1%8.018.013.020.5%13.021.015.026.5%
Dividend per Share0.00.03.00.0%0.00.011.00.0%0.00.019.00.0%0.00.039.00.0%0.00.049.00.0%
Total Gains per Share1.01.01.033.3%2.07.02.018.2%4.09.06.021.1%8.018.013.020.5%13.021.015.026.5%

Fundamentals of Celyad

About Celyad SA

Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; Multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery / PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.

Fundamental data was last updated by Penke on 2024-05-01 06:30:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Celyad SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Celyad earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Net Profit Margin of -8,117.2% means that €-81.17 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Celyad SA:

  • The MRQ is -8,117.2%. The company is making a huge loss. -2
  • The TTM is -5,539.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-8,117.2%TTM-5,539.1%-2,578.2%
TTM-5,539.1%YOY--5,539.1%
TTM-5,539.1%5Y-90,799.5%+85,260.4%
5Y-90,799.5%10Y-157,226.2%+66,426.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,117.2%-207.2%-7,910.0%
TTM-5,539.1%-216.8%-5,322.3%
YOY--282.4%+282.4%
5Y-90,799.5%-426.4%-90,373.1%
10Y-157,226.2%-589.3%-156,636.9%
1.1.2. Return on Assets

Shows how efficient Celyad is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • -28.9% Return on Assets means that Celyad generated €-0.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Celyad SA:

  • The MRQ is -28.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.9%TTM-23.0%-5.9%
TTM-23.0%YOY-44.6%+21.6%
TTM-23.0%5Y-18.9%-4.1%
5Y-18.9%10Y-13.7%-5.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.9%-13.0%-15.9%
TTM-23.0%-12.5%-10.5%
YOY-44.6%-11.2%-33.4%
5Y-18.9%-13.6%-5.3%
10Y-13.7%-15.2%+1.5%
1.1.3. Return on Equity

Shows how efficient Celyad is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • 0.0% Return on Equity means Celyad generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Celyad SA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-124.4%+124.4%
TTM-124.4%YOY-21.3%-103.1%
TTM-124.4%5Y-37.8%-86.6%
5Y-37.8%10Y-25.5%-12.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.6%+16.6%
TTM-124.4%-15.7%-108.7%
YOY-21.3%-14.2%-7.1%
5Y-37.8%-18.9%-18.9%
10Y-25.5%-19.9%-5.6%

1.2. Operating Efficiency of Celyad SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Celyad is operating .

  • Measures how much profit Celyad makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • An Operating Margin of -8,263.8% means the company generated €-82.64  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Celyad SA:

  • The MRQ is -8,263.8%. The company is operating very inefficient. -2
  • The TTM is -7,166.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8,263.8%TTM-7,166.7%-1,097.1%
TTM-7,166.7%YOY--7,166.7%
TTM-7,166.7%5Y-75,247.8%+68,081.1%
5Y-75,247.8%10Y-149,131.1%+73,883.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8,263.8%-285.4%-7,978.4%
TTM-7,166.7%-226.2%-6,940.5%
YOY--288.4%+288.4%
5Y-75,247.8%-469.6%-74,778.2%
10Y-149,131.1%-599.3%-148,531.8%
1.2.2. Operating Ratio

Measures how efficient Celyad is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 83.64 means that the operating costs are €83.64 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Celyad SA:

  • The MRQ is 83.638. The company is inefficient in keeping operating costs low. -1
  • The TTM is 72.334. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ83.638TTM72.334+11.304
TTM72.334YOY-+72.334
TTM72.3345Y122.961-50.627
5Y122.96110Y38.385+84.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ83.6383.231+80.407
TTM72.3343.303+69.031
YOY-3.763-3.763
5Y122.9615.586+117.375
10Y38.3857.464+30.921

1.3. Liquidity of Celyad SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Celyad is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.79 means the company has €3.79 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Celyad SA:

  • The MRQ is 3.793. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.106. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.793TTM2.106+1.687
TTM2.106YOY1.782+0.325
TTM2.1065Y2.293-0.187
5Y2.29310Y3.886-1.593
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7933.855-0.062
TTM2.1064.160-2.054
YOY1.7825.323-3.541
5Y2.2936.122-3.829
10Y3.8866.480-2.594
1.3.2. Quick Ratio

Measures if Celyad is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Quick Ratio of 3.34 means the company can pay off €3.34 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Celyad SA:

  • The MRQ is 3.337. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.614. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.337TTM1.614+1.723
TTM1.614YOY1.346+0.268
TTM1.6145Y1.467+0.147
5Y1.46710Y3.341-1.874
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3373.506-0.169
TTM1.6144.001-2.387
YOY1.3465.390-4.044
5Y1.4676.127-4.660
10Y3.3416.488-3.147

1.4. Solvency of Celyad SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Celyad assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Celyad to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.63 means that Celyad assets are financed with 163.4% credit (debt) and the remaining percentage (100% - 163.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Celyad SA:

  • The MRQ is 1.634. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.392. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.634TTM1.392+0.243
TTM1.392YOY0.782+0.610
TTM1.3925Y0.728+0.664
5Y0.72810Y0.532+0.195
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6340.344+1.290
TTM1.3920.339+1.053
YOY0.7820.275+0.507
5Y0.7280.368+0.360
10Y0.5320.389+0.143
1.4.2. Debt to Equity Ratio

Measures if Celyad is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Celyad to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Celyad SA:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.999-3.999
TTM3.999YOY0.754+3.244
TTM3.9995Y1.573+2.426
5Y1.57310Y1.041+0.532
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.390-0.390
TTM3.9990.408+3.591
YOY0.7540.341+0.413
5Y1.5730.438+1.135
10Y1.0410.469+0.572

2. Market Valuation of Celyad SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Celyad generates.

  • Above 15 is considered overpriced but always compare Celyad to the Biotechnology industry mean.
  • A PE ratio of -0.86 means the investor is paying €-0.86 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Celyad SA:

  • The EOD is -0.678. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.858. Based on the earnings, the company is expensive. -2
  • The TTM is -2.821. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.678MRQ-0.858+0.180
MRQ-0.858TTM-2.821+1.963
TTM-2.821YOY-1.810-1.010
TTM-2.8215Y-19.361+16.541
5Y-19.36110Y-36.244+16.883
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.678-2.351+1.673
MRQ-0.858-2.599+1.741
TTM-2.821-2.762-0.059
YOY-1.810-4.025+2.215
5Y-19.361-6.305-13.056
10Y-36.244-6.538-29.706
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Celyad SA:

  • The EOD is -0.428. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.542. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.068. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.428MRQ-0.542+0.114
MRQ-0.542TTM-1.068+0.526
TTM-1.068YOY-1.044-0.023
TTM-1.0685Y-6.761+5.693
5Y-6.76110Y-29.234+22.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.428-3.010+2.582
MRQ-0.542-3.306+2.764
TTM-1.068-3.607+2.539
YOY-1.044-5.524+4.480
5Y-6.761-8.299+1.538
10Y-29.234-8.910-20.324
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Celyad is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.56 means the investor is paying €-1.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Celyad SA:

  • The EOD is -1.236. Based on the equity, the company is expensive. -2
  • The MRQ is -1.565. Based on the equity, the company is expensive. -2
  • The TTM is 5.598. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-1.236MRQ-1.565+0.329
MRQ-1.565TTM5.598-7.163
TTM5.598YOY1.273+4.326
TTM5.5985Y7.177-1.579
5Y7.17710Y15.717-8.540
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.2362.019-3.255
MRQ-1.5652.116-3.681
TTM5.5982.099+3.499
YOY1.2732.873-1.600
5Y7.1773.556+3.621
10Y15.7173.946+11.771
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Celyad SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.2740.016-1813%-0.338+23%-0.084-69%-0.017-94%
Book Value Per Share---0.249-0.174-30%0.516-148%0.619-140%1.217-120%
Current Ratio--3.7932.106+80%1.782+113%2.293+65%3.886-2%
Debt To Asset Ratio--1.6341.392+17%0.782+109%0.728+125%0.532+207%
Debt To Equity Ratio---3.999-100%0.754-100%1.573-100%1.041-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.114-0.068-40%-0.247+117%-0.171+51%-0.194+71%
Free Cash Flow Per Share---0.180-0.165-9%-0.274+52%-0.200+11%-0.190+6%
Free Cash Flow To Equity Per Share--0.048-0.090+286%-0.233+581%-0.070+245%0.217-78%
Gross Profit Margin--1.0181.0180%1.008+1%1.004+1%1.012+1%
Intrinsic Value_10Y_max---8.556--------
Intrinsic Value_10Y_min---9.068--------
Intrinsic Value_1Y_max---0.776--------
Intrinsic Value_1Y_min---0.951--------
Intrinsic Value_3Y_max---2.394--------
Intrinsic Value_3Y_min---2.839--------
Intrinsic Value_5Y_max---4.087--------
Intrinsic Value_5Y_min---4.689--------
Market Cap12760008.800-27%16157154.00024346207.267-34%60837899.100-73%227534593.011-93%815949024.262-98%
Net Profit Margin---81.172-55.391-32%--100%-907.995+1019%-1572.262+1837%
Operating Margin---82.638-71.667-13%--100%-752.478+811%-1491.311+1705%
Operating Ratio--83.63872.334+16%-+100%122.961-32%38.385+118%
Pb Ratio-1.236+21%-1.5655.598-128%1.273-223%7.177-122%15.717-110%
Pe Ratio-0.678+21%-0.858-2.821+229%-1.810+111%-19.361+2157%-36.244+4124%
Price Per Share0.308-27%0.3900.588-34%1.469-73%5.492-93%19.695-98%
Price To Free Cash Flow Ratio-0.428+21%-0.542-1.068+97%-1.044+93%-6.761+1148%-29.234+5295%
Price To Total Gains Ratio-1.125+21%-1.4240.099-1539%-8.406+490%-6.461+354%-1018242.563+71503706%
Quick Ratio--3.3371.614+107%1.346+148%1.467+128%3.3410%
Return On Assets---0.289-0.230-20%-0.446+54%-0.189-35%-0.137-53%
Return On Equity----1.2440%-0.2130%-0.3780%-0.2550%
Total Gains Per Share---0.2740.016-1813%-0.338+23%-0.084-69%-0.017-94%
Usd Book Value---11117015.500-7758694.333-30%23004535.875-148%27594887.684-140%54256564.158-120%
Usd Book Value Change Per Share---0.2950.017-1813%-0.363+23%-0.090-69%-0.018-94%
Usd Book Value Per Share---0.268-0.187-30%0.555-148%0.666-140%1.310-120%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.122-0.073-40%-0.266+117%-0.184+51%-0.209+71%
Usd Free Cash Flow---8025307.500-7341550.225-9%-9148231.563+14%-7035210.733-12%-7617527.892-5%
Usd Free Cash Flow Per Share---0.194-0.177-9%-0.294+52%-0.215+11%-0.205+6%
Usd Free Cash Flow To Equity Per Share--0.052-0.097+286%-0.250+581%-0.076+245%0.233-78%
Usd Market Cap13736149.473-27%17393176.28126208692.123-34%65491998.381-73%244940989.376-93%878369124.618-98%
Usd Price Per Share0.332-27%0.4200.633-34%1.581-73%5.912-93%21.202-98%
Usd Profit---5068162.000-3702442.333-27%-14593706.813+188%-8485057.987+67%-8839893.670+74%
Usd Revenue--62437.00036601.000+71%-+100%6742.289+826%518707.385-88%
Usd Total Gains Per Share---0.2950.017-1813%-0.363+23%-0.090-69%-0.018-94%
 EOD+2 -6MRQTTM+8 -25YOY+21 -125Y+18 -1510Y+12 -21

3.2. Fundamental Score

Let's check the fundamental score of Celyad SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.678
Price to Book Ratio (EOD)Between0-1-1.236
Net Profit Margin (MRQ)Greater than0-81.172
Operating Margin (MRQ)Greater than0-82.638
Quick Ratio (MRQ)Greater than13.337
Current Ratio (MRQ)Greater than13.793
Debt to Asset Ratio (MRQ)Less than11.634
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.289
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Celyad SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.750
Ma 20Greater thanMa 500.332
Ma 50Greater thanMa 1000.349
Ma 100Greater thanMa 2000.363
OpenGreater thanClose0.310
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets16,282
Total Liabilities26,609
Total Stockholder Equity-10,327
 As reported
Total Liabilities 26,609
Total Stockholder Equity+ -10,327
Total Assets = 16,282

Assets

Total Assets16,282
Total Current Assets11,121
Long-term Assets5,161
Total Current Assets
Cash And Cash Equivalents 7,004
Net Receivables 2,780
Other Current Assets 1,337
Total Current Assets  (as reported)11,121
Total Current Assets  (calculated)11,121
+/-0
Long-term Assets
Property Plant Equipment 1,830
Intangible Assets 48
Long-term Assets Other 2,941
Long-term Assets  (as reported)5,161
Long-term Assets  (calculated)4,819
+/- 342

Liabilities & Shareholders' Equity

Total Current Liabilities2,932
Long-term Liabilities23,677
Total Stockholder Equity-10,327
Total Current Liabilities
Short-term Debt 156
Accounts payable 1,243
Other Current Liabilities 1,024
Total Current Liabilities  (as reported)2,932
Total Current Liabilities  (calculated)2,423
+/- 509
Long-term Liabilities
Long-term Liabilities  (as reported)23,677
Long-term Liabilities  (calculated)0
+/- 23,677
Total Stockholder Equity
Common Stock32,949
Retained Earnings -358,372
Accumulated Other Comprehensive Income 315,096
Other Stockholders Equity 0
Total Stockholder Equity (as reported)-10,327
Total Stockholder Equity (calculated)-10,327
+/-0
Other
Cash and Short Term Investments 7,004
Common Stock Shares Outstanding 28,900
Current Deferred Revenue509
Liabilities and Stockholders Equity 16,282
Net Debt 10,685
Net Working Capital 8,189
Short Long Term Debt Total 17,689



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-31
> Total Assets 
17,495
0
0
0
13,813
0
0
12,485
13,746
10,654
15,046
32,386
32,386
51,805
51,804
43,976
43,976
183,297
183,297
159,525
159,524
139,993
139,993
138,806
138,807
120,295
120,295
77,626
77,626
109,057
109,057
94,299
94,299
81,358
81,358
89,836
89,836
0
75,760
0
66,084
62,101
62,688
58,197
79,943
69,217
63,140
0
19,716
0
12,178
16,282
16,28212,178019,716063,14069,21779,94358,19762,68862,10166,084075,760089,83689,83681,35881,35894,29994,299109,057109,05777,62677,626120,295120,295138,807138,806139,993139,993159,524159,525183,297183,29743,97643,97651,80451,80532,38632,38615,04610,65413,74612,4850013,81300017,495
   > Total Current Assets 
0
0
0
0
0
0
0
0
2,192
0
4,994
0
22,602
0
42,241
0
32,935
0
125,663
0
109,419
0
88,324
85,366
85,367
70,862
70,862
36,394
36,394
67,003
67,003
51,692
51,692
35,475
35,475
42,836
42,836
29,439
29,439
19,705
19,705
15,833
16,594
12,169
34,292
26,088
19,380
14,825
14,825
7,694
7,694
11,121
11,1217,6947,69414,82514,82519,38026,08834,29212,16916,59415,83319,70519,70529,43929,43942,83642,83635,47535,47551,69251,69267,00367,00336,39436,39470,86270,86285,36785,36688,3240109,4190125,663032,935042,241022,60204,99402,19200000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
1,645
0
3,943
0
19,058
0
35,071
0
27,633
0
116,118
0
100,175
0
53,693
48,357
48,357
23,449
23,449
23,253
23,253
62,385
62,385
40,542
40,542
33,668
33,668
39,338
39,338
0
26,692
0
17,234
12,133
12,017
6,098
30,018
20,512
14,385
0
12,445
0
4,976
7,004
7,0044,976012,445014,38520,51230,0186,09812,01712,13317,234026,692039,33839,33833,66833,66840,54240,54262,38562,38523,25323,25323,44923,44948,35748,35753,6930100,1750116,118027,633035,071019,05803,94301,64500000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
3,000
0
5,000
0
2,671
0
7,671
0
7,338
0
32,338
34,230
34,230
45,386
45,386
10,653
10,653
843
843
9,197
9,197
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000009,1979,19784384310,65310,65345,38645,38634,23034,23032,33807,33807,67102,67105,00003,000000000000000
       Net Receivables 
1,988
0
0
0
1,013
0
0
443
443
281
303
422
421
125
125
1,718
1,717
733
733
1,075
1,075
1,367
1,367
1,503
1,503
1,318
1,318
1,592
1,592
271
271
1,269
1,269
398
398
2,702
2,702
2,123
2,123
907
907
1,406
2,935
3,907
2,340
3,346
3,716
1,259
1,259
2,091
2,096
2,780
2,7802,0962,0911,2591,2593,7163,3462,3403,9072,9351,4069079072,1232,1232,7022,7023983981,2691,2692712711,5921,5921,3181,3181,5031,5031,3671,3671,0751,0757337331,7171,718125125421422303281443443001,0130001,988
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,137
0
-3,250
0
0
0
0
0
00000-3,2500-2,13700000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
11,554
0
10,051
0
9,783
0
9,563
0
11,041
0
57,634
0
50,105
0
51,669
0
53,440
0
49,433
0
41,232
0
42,054
0
42,607
0
45,883
0
47,000
0
46,321
0
46,379
46,268
46,094
46,028
45,651
43,129
43,760
0
4,891
0
4,484
5,161
5,1614,48404,891043,76043,12945,65146,02846,09446,26846,379046,321047,000045,883042,607042,054041,232049,433053,440051,669050,105057,634011,04109,56309,783010,051011,55400000000
       Property Plant Equipment 
592
0
0
0
356
0
0
383
383
327
290
243
243
402
402
598
598
683
683
1,136
1,136
3,618
3,618
3,563
3,563
3,054
3,054
3,290
3,290
3,148
3,148
3,014
3,014
5,525
5,525
5,061
5,061
4,231
4,231
4,119
4,119
3,807
3,592
3,419
3,248
3,008
2,855
309
309
848
848
1,830
1,8308488483093092,8553,0083,2483,4193,5923,8074,1194,1194,2314,2315,0615,0615,5255,5253,0143,0143,1483,1483,2903,2903,0543,0543,5633,5633,6183,6181,1361,13668368359859840240224324329032738338300356000592
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,003
1,003
989
989
1,040
1,040
960
960
914
914
883
883
883
883
883
883
883
883
0
883
0
883
0
883
0
883
0
883
0
0
0
0
0
00000883088308830883088308838838838838838838838839149149609601,0401,0409899891,0031,0030000000000000000000
       Intangible Assets 
10,206
0
0
0
9,625
0
0
9,087
9,087
8,934
9,562
8,475
9,400
9,064
9,063
9,355
10,266
55,910
56,823
47,917
47,786
47,020
46,869
48,761
48,526
45,315
45,127
35,769
35,594
33,678
34,383
34,608
35,281
34,564
35,204
34,709
35,316
0
35,223
0
35,288
0
35,244
0
35,285
0
35,706
0
864
0
645
48
486450864035,706035,285035,244035,288035,223035,31634,70935,20434,56435,28134,60834,38333,67835,59435,76945,12745,31548,52648,76146,86947,02047,78647,91756,82355,91010,2669,3559,0639,0649,4008,4759,5628,9349,0879,087009,62500010,206
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
199
0
140
0
98
0
109
0
128
0
180
0
193
0
311
0
292
0
1,434
0
3,640
0
3,429
0
4,271
0
5,740
0
5,984
0
6,089
6,280
6,375
6,535
6,235
4,154
4,316
0
3,718
0
2,991
2,941
2,9412,99103,71804,3164,1546,2356,5356,3756,2806,08905,98405,74004,27103,42903,64001,434029203110193018001280109098014001990000000000
> Total Liabilities 
8,805
0
0
0
10,070
0
0
14,745
15,058
15,090
16,168
15,488
15,488
16,127
16,127
17,292
17,292
58,409
58,409
48,052
48,052
43,365
43,365
47,921
47,921
43,043
43,043
30,091
30,091
36,373
36,373
38,710
38,710
40,439
40,439
44,217
44,217
0
45,442
0
35,090
36,782
37,827
39,154
36,304
32,724
32,490
0
32,030
0
11,159
26,609
26,60911,159032,030032,49032,72436,30439,15437,82736,78235,090045,442044,21744,21740,43940,43938,71038,71036,37336,37330,09130,09143,04343,04347,92147,92143,36543,36548,05248,05258,40958,40917,29217,29216,12716,12715,48815,48816,16815,09015,05814,7450010,0700008,805
   > Total Current Liabilities 
2,242
0
0
0
2,106
0
0
3,479
2,731
3,810
3,955
3,389
3,389
4,382
4,382
6,053
6,053
8,599
8,599
11,490
11,490
9,330
9,330
11,275
11,275
12,823
12,823
7,945
7,945
10,133
10,133
9,647
9,647
8,916
8,916
11,922
11,922
10,798
10,798
11,834
11,834
11,115
12,537
12,529
13,827
10,129
11,356
10,426
10,426
6,092
6,092
2,932
2,9326,0926,09210,42610,42611,35610,12913,82712,52912,53711,11511,83411,83410,79810,79811,92211,9228,9168,9169,6479,64710,13310,1337,9457,94512,82312,82311,27511,2759,3309,33011,49011,4908,5998,5996,0536,0534,3824,3823,3893,3893,9553,8102,7313,479002,1060002,242
       Short-term Debt 
0
0
0
0
0
0
0
0
248
0
102
0
79
0
67
0
134
0
163
0
248
0
538
1,478
561
1,199
554
1,444
636
283
582
281
765
277
1,444
192
1,359
0
1,195
0
1,113
1,058
977
953
902
841
783
0
137
0
185
156
156185013707838419029539771,0581,11301,19501,3591921,4442777652815822836361,4445541,1995611,4785380248016301340670790102024800000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,478
1,478
1,199
1,199
1,444
1,444
283
283
281
281
277
277
192
192
0
91
0
37
19
0
0
0
0
0
0
0
0
0
0
0000000000193709101921922772772812812832831,4441,4441,1991,1991,4781,47800000000000000000000000
       Accounts payable 
1,287
0
0
0
1,086
0
0
1,770
1,770
1,833
2,626
2,169
2,169
3,026
3,026
4,042
4,042
6,395
6,395
8,576
8,576
5,668
5,668
8,098
8,098
4,620
4,620
4,800
4,800
6,441
6,441
5,916
5,916
5,439
5,439
6,969
6,969
5,782
5,782
4,736
4,736
4,532
5,582
5,624
6,611
5,510
6,008
4,752
4,752
3,411
3,411
1,243
1,2433,4113,4114,7524,7526,0085,5106,6115,6245,5824,5324,7364,7365,7825,7826,9696,9695,4395,4395,9165,9166,4416,4414,8004,8004,6204,6208,0988,0985,6685,6688,5768,5766,3956,3954,0424,0423,0263,0262,1692,1692,6261,8331,7701,770001,0860001,287
       Other Current Liabilities 
664
0
0
0
830
0
0
1,548
712
1,868
593
1,141
712
1,289
860
1,877
1,100
2,041
1,264
2,666
1,768
3,124
1,821
2,616
1,508
7,649
6,518
2,509
2,283
1,041
2,819
1,300
2,690
566
1,689
1,362
3,248
2,176
3,208
4,013
3,776
5,184
4,140
5,602
4,856
3,435
3,017
4,149
5,100
1,755
1,733
1,024
1,0241,7331,7555,1004,1493,0173,4354,8565,6024,1405,1843,7764,0133,2082,1763,2481,3621,6895662,6901,3002,8191,0412,2832,5096,5187,6491,5082,6161,8213,1241,7682,6661,2642,0411,1001,8778601,2897121,1415931,8687121,54800830000664
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
12,328
0
12,213
0
12,099
0
11,745
0
11,239
0
49,810
0
36,562
0
34,035
0
36,646
0
30,220
0
22,146
0
26,240
0
29,063
0
31,523
0
32,295
0
34,644
0
23,256
25,667
25,290
26,625
22,477
22,595
21,134
0
21,604
0
5,067
23,677
23,6775,067021,604021,13422,59522,47726,62525,29025,66723,256034,644032,295031,523029,063026,240022,146030,220036,646034,035036,562049,810011,239011,745012,099012,213012,32800000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
717
0
881
0
3,490
0
3,004
0
2,509
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002,50903,00403,49008810717000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-248
0
-102
0
-79
0
-67
0
-134
0
-163
0
-248
0
-538
-1,478
-561
-1,199
-554
-1,444
-636
-283
-582
-281
-765
-277
3,122
-192
2,775
0
2,418
0
2,488
2,322
2,104
1,914
1,730
1,555
1,381
0
-137
0
351
-156
-1563510-13701,3811,5551,7301,9142,1042,3222,48802,41802,775-1923,122-277-765-281-582-283-636-1,444-554-1,199-561-1,478-5380-2480-1630-1340-670-790-1020-24800000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
371
265
150
29
164
167
178
0
0
0
217
0
02170001781671642915026537100000-10000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
805
805
772
772
739
739
705
705
673
673
640
640
607
607
573
573
541
541
0
507
0
474
0
441
408
408
375
375
0
037537540840844104740507054154157357360760764064067367370570573973977277280580500000000000000000000000
> Total Stockholder Equity
8,690
0
0
0
3,743
3,743
0
0
-1,312
0
-1,122
16,898
16,898
35,677
35,677
26,684
26,684
124,888
124,888
111,473
111,473
96,628
96,628
90,885
90,884
77,252
77,251
47,535
47,535
72,684
72,684
55,589
55,591
40,919
40,919
45,619
45,619
0
30,318
0
30,994
25,319
24,861
19,043
43,639
36,493
30,650
0
-12,314
0
1,019
-10,327
-10,3271,0190-12,314030,65036,49343,63919,04324,86125,31930,994030,318045,61945,61940,91940,91955,59155,58972,68472,68447,53547,53577,25177,25290,88490,88596,62896,628111,473111,473124,888124,88826,68426,68435,67735,67716,89816,898-1,1220-1,312003,7433,7430008,690
   Retained Earnings -358,372-353,687-353,687-349,947-349,947-323,053-316,570-308,997-70,718-63,331-100,527-91,826-91,826-91,021-91,021-74,424-74,424-61,456-61,456-217,778-217,778-198,880-198,880-180,421-180,421-138,441-138,441-124,026-124,026-117,2390-100,3130-85,9960-71,2150-42,2890-36,3880-30,4700-11,28700000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
-1,872
0
0
0
19,982
0
20,437
0
21,205
0
23,286
0
24,329
0
21,950
0
23,322
0
23,863
0
25,667
0
26,960
0
28,181
0
29,477
0
30,958
31,535
32,062
32,668
267,734
268,161
268,801
0
252,731
0
269,804
315,096
315,096269,8040252,7310268,801268,161267,73432,66832,06231,53530,958029,477028,181026,960025,667023,863023,322021,950024,329023,286021,205020,437019,982000-1,872000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
206,148
0
206,149
0
33,862
0
43,349
0
43,349
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000043,349043,349033,8620206,1490206,148000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue102
Cost of Revenue--787
Gross Profit889889
 
Operating Income (+$)
Gross Profit889
Operating Expense-11,486
Operating Income-10,597-10,597
 
Operating Expense (+$)
Research Development3,881
Selling General Administrative5,707
Selling And Marketing Expenses215
Operating Expense11,4869,803
 
Net Interest Income (+$)
Interest Income0
Interest Expense-84
Other Finance Cost-84
Net Interest Income0
 
Pretax Income (+$)
Operating Income-10,597
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,639-12,555
EBIT - interestExpense = -10,681
-8,639
-8,364
Interest Expense84
Earnings Before Interest and Taxes (EBIT)-10,597-8,555
Earnings Before Interest and Taxes (EBITDA)-9,803
 
After tax Income (+$)
Income Before Tax-8,639
Tax Provision-0
Net Income From Continuing Ops0-8,639
Net Income-8,448
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses10,699
Total Other Income/Expenses Net1,9580
 

Technical Analysis of Celyad
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Celyad. The general trend of Celyad is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Celyad's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Celyad SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.375 < 0.4 < 0.47.

The bearish price targets are: 0.3055 > 0.2975.

Tweet this
Celyad SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Celyad SA. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Celyad SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Celyad SA. The current macd is -0.00981235.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celyad price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Celyad. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Celyad price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Celyad SA Daily Moving Average Convergence/Divergence (MACD) ChartCelyad SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Celyad SA. The current adx is 13.08.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Celyad shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Celyad SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Celyad SA. The current sar is 0.35034447.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Celyad SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Celyad SA. The current rsi is 39.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Celyad SA Daily Relative Strength Index (RSI) ChartCelyad SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Celyad SA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Celyad price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Celyad SA Daily Stochastic Oscillator ChartCelyad SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Celyad SA. The current cci is -116.69724771.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Celyad SA Daily Commodity Channel Index (CCI) ChartCelyad SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Celyad SA. The current cmo is -25.26896382.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Celyad SA Daily Chande Momentum Oscillator (CMO) ChartCelyad SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Celyad SA. The current willr is -92.75362319.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Celyad SA Daily Williams %R ChartCelyad SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Celyad SA.

Celyad SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Celyad SA. The current atr is 0.02221386.

Celyad SA Daily Average True Range (ATR) ChartCelyad SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Celyad SA. The current obv is 268,246.

Celyad SA Daily On-Balance Volume (OBV) ChartCelyad SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Celyad SA. The current mfi is 43.25.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Celyad SA Daily Money Flow Index (MFI) ChartCelyad SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Celyad SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Celyad SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Celyad SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.750
Ma 20Greater thanMa 500.332
Ma 50Greater thanMa 1000.349
Ma 100Greater thanMa 2000.363
OpenGreater thanClose0.310
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Celyad with someone you think should read this too:
  • Are you bullish or bearish on Celyad? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Celyad? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Celyad SA

I send you an email if I find something interesting about Celyad SA.


Comments

How you think about this?

Leave a comment

Stay informed about Celyad SA.

Receive notifications about Celyad SA in your mailbox!